Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fludarabine for chronic lymphocytic leukemia

M Marchetti, G Barosi, L N Liberato

    The New England Journal of Medicine
    |April 17, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

    Leukemia·2017
    Same author

    A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

    Leukemia·2016
    Same author

    Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

    Leukemia·2016
    Same author

    How can we know if new drugs are effective in myeloproliferative neoplasm-associated myelofibrosis?

    Leukemia·2016
    Same author

    JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.

    Leukemia·2016
    Same author

    Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

    Leukemia·2016